Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27073190 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Simin Jamaly und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Oslo University Hospital, Rikshospitalet, 0372 Oslo, Norway. Hauptthemen laut MEDLINE: Calcium-Calmodulin-Dependent Protein Kinase Type 4, Lupus Nephritis, Tertiary Lymphoid Structures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID, Health Region South-East.
Abstract (Originalsprache)
Current treatment of lupus nephritis (LN) relies on broad immunosuppression and often fails to eradicate intrarenal immune niches that sustain inflammation. Tertiary lymphoid structures (TLS)—organized aggregates of immune cells forming in chronically inflamed non-lymphoid tissues—are increasingly recognized as drivers of local immune activation and tissue injury in LN. We previously showed that genetic CaMK4 deficiency suppresses autoimmunity and nephritis in lupus-prone mice. Here, we tested whether CaMK4 regulates renal TLS-like organization. Using kidneys from MRL/lpr mice that were CaMK4-deficient or treated with KN93-loaded nanoparticles targeted to CD4+ T cells or podocytes (anti-podocin), we compared findings with vehicle-treated controls. TLS-associated inflammation and maturation were quantified by mean fluorescence intensity of CD3, CD20, Ki67, and α-SMA. Across genetic and targeted-treatment arms, CaMK4 inhibition reduced all assessed markers, with uniform suppression of CD20 signal, highlighting a key role for B cells in TLS maintenance. Notably, podocyte-targeted KN93 most strongly suppressed TLS-like formation, implicating podocyte-driven pathways in interstitial inflammation and lymphoid neogenesis through previously underappreciated mechanisms. These data identify CaMK4 as a regulator of TLS-like architecture in LN and support the translational potential of cell-targeted CaMK4 inhibition to disrupt local immune recruitment while limiting systemic toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Oslo University Hospital, Rikshospitalet, 0372 Oslo, Norway.
- Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
- Department of Cancer Genetics, Oslo University Hospital, Radiumhospitalet, 0310 Oslo, Norway.
ORCID-Profile: Kunihiro Ichinose, Maria G Tsokos, George C Tsokos
Förderung
- NIAID
- Health Region South-East
Zitieren
APA
Jamaly, S., Rakaee, M., Ichinose, K., Maeda, K., Otomo, K., Koga, T., Tsokos, M. G., & Tsokos, G. C. (2026). Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27073190
Vancouver
Jamaly S, Rakaee M, Ichinose K, Maeda K, Otomo K, Koga T, et al. Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27073190
BibTeX
@article{Jamaly2026,
author = {Jamaly, Simin and Rakaee, Mehrdad and Ichinose, Kunihiro and Maeda, Kayaho and Otomo, Kotaro and Koga, Tomohiro and Tsokos, Maria G and Tsokos, George C},
title = {Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27073190}
}
EUVIMED